NCT03329989 - Safety and Effectiveness of EN3835 in the Treatment of EFP in Women | Biotech Hunter

Enrollment

158

Participants

Timeline

Start Date

November 17, 2017

Primary Completion Date

September 5, 2018

Study Completion Date

September 5, 2018

Conditions

Edematous Fibrosclerotic PanniculopathyCellulite

Interventions

BIOLOGICAL

Collagenase Clostridium Histolyticum

During 3 treatment visits 12 injections will be given per treatment area

Trial Locations (11)

Endo Clinical Trial Site #9, New York

Endo Clinical Trial Site #8, Alpharetta

Endo Clinical Trial Site #5, Coral Gables

Endo Clinical Trial Site #7, West Palm Beach

Endo Clinical Trial Site #6, Tampa

Endo Clinical Trial Site #10, Franklin

Endo Clinical Trial Site #11, Austin

Endo Clinical Trial Site #1, Scottsdale

Endo Clinical Trial Site #4, Santa Monica

Endo Clinical Trial Site #3, San Diego

Endo Clinical Trial Site #2, Huntington Beach